Already a member? Sign in
Category: Supplements
Most Popular Types: Toco 500, D-Alpha Tocopheryl Acetate, GNC Vitamin E (Show all)
Antioxidants such as vitamin E act to protect your cells against the effects of free radicals, which are potentially damaging by-products of energy metabolism. It is the collective name for a set of 8 related tocopherols and tocotrienols, fat-soluble vitamins with antioxidant properties.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| General health | 477 | 59 |
|
|
|
|
|
| ALS (Amyotrophic Lateral Sclerosis) | 245 | 32 |
|
|
|
|
|
| Other | 49 | 7 |
|
|
|||
| MS (Multiple Sclerosis) | 38 | 7 |
|
|
|||
| Parkinson's Disease | 21 | 1 |
|
||||
| Don't know | 17 | 4 |
|
|
See all 898 patients currently taking Vitamin E
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Vitamin E
| Bruising | 1 |
|---|
Frequently reported dosages based on patients currently taking Vitamin E. See all 79 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Other | 83 | ||
| Did not seem to work | 63 | ||
| Personal research | 30 | ||
| Doctor's advice | 23 | ||
| Not indicated | 16 | ||
| Expense | 12 | ||
| Course of treatment ended | 5 | ||
| Side effects too severe | 3 | ||
| Change in health plan coverage | 3 |
Adherence
Taking treatment as prescribed
Adherence of Vitamin E
Always |
77 | 58% |
|
|---|---|---|---|
Usually |
39 | 30% |
|
Sometimes |
7 | 5% |
|
Never |
9 | 7% |
|
Burden
Difficulty being on treatment
Burden of Vitamin E
Very |
3 | 2% |
|
|---|---|---|---|
Somewhat |
4 | 3% |
|
A little |
12 | 9% |
|
Not at all |
113 | 86% |
|
Cost
Paid out of pocket
Cost of Vitamin E
$200+ |
1 | 1% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
2 | 3% |
|
$25-49 |
3 | 4% |
|
< $25 |
66 | 92% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 10, 2012.